A Phase 4 interventional study of MEDICLORE in Adhesion and Thyroidectomy, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-03-17.
Sponsored by Seoul National University Hospital · Phase 4, Interventional, and Prevention
One of most important complication of thyroid surgery is adhesion. There are many anti-adhesive materials, but none of them showed significant outcomes. The investigators planned double blind prospective study of "Thermo-sensitive Adhesion Barrier (MEDICLORE)" to reveal anti-adhesive effect of MEDICLORE. The investigators will recruit total 90 patients (control group 45, experimental group 45) and compare postoperative outcomes about adhesion.
Exclusion Criteria:
use mediclore at the end of surgery
Combination Product: MEDICLORE
use no antiadhesive product at the end of surgery
use MEDICLORE at the end of surgery as antiadhesive product
Changes of postoperative adhesion will checked using answer of questionnaire that participants and physicians replied.
Time frame: Participants will be followed from the operation to postoperative 2weeks, 3months, 6months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital